Diphencyprone reduces the CD8+ lymphocytes and IL-4 and enhences IgG2a/IgG1 ratio in pathogenicity of acute leishmania major infection in BALB/c mice
Abstract
No abstract availableKeywords
Funding Information
- Mashhad University of Medical Sciences
This publication has 89 references indexed in Scilit:
- Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management DevelopmentsAmerican Journal of Clinical Dermatology, 2022
- A Review of Leishmaniasis: Current Knowledge and Future DirectionsCurrent Tropical Medicine Reports, 2021
- Implications of asymptomatic infection for the natural history of selected parasitic tropical diseasesSeminars in Immunopathology, 2020
- CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the uglySeminars in Immunopathology, 2015
- Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanomaJournal of Surgical Oncology, 2013
- Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyproneArchives of Dermatological Research, 2007
- Leishmania major and L. donovani: A method for rapid purification of amastigotesExperimental Parasitology, 2004
- Parasite dose determines the Th1/Th2 nature of the response toLeishmania major independently of infection route and strain of host or parasiteEuropean Journal of Immunology, 1998
- In susceptible mice, Leishmania major induce very rapid interleukin‐4 production by CD4+ T cells which are NK1.1−European Journal of Immunology, 1995
- Involvement of specific Lyt‐2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasisEuropean Journal of Immunology, 1987